Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-phenylglycinamide CCK antagonists and pharmaceutical compositions containing them

N-phenylglycinamide CCK antagonists and pharmaceutical compositions containing them

US Patent 5475106 · Granted Dec 12, 1995

Estimated economic value: $20,034,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymorph form of pitolisant hydrochloride2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2022
Molecularly imprinted polymer of sol-gel type for selectively trapping odorous m2022
Therapeutical use of H3-ligands2021
Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical composi2021
Molecularly imprinted polymers and their use as antidandruff agents2020
Molecularly imprinted polymer for selectively trapping odorous molecules2020
Piperidinyl monocarboxylic acids as S1P1 receptor agonists2016
6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 recep2016
(Aza)benzhydryl ether derivatives, their process of preparation and their use as2016
Benzazole derivatives as histamine H4 receptor ligands2015